The authors chose to use a lipophilic linker to have a better binding affinity to PSMA; nevertheless, despite the fact they observed rapid blood clearance, high tumor uptake, and low uptake in normal tissues and excretory organs in preclinical studies, binding experiments showed a relatively low affinity [22]. Here, FOLH1 is linked to neoplasm.